Sadly, there is no cure for Huntington’s disease. But a couple new research papers suggests this may be about to change.

Researchers determine the impact of light physical activity on mortality in people with cardiovascular-kidney-metabolic ...

Light physical activity may help lower death risk in cardiovascular-kidney-metabolic syndrome, a condition that includes ...

Wildlife officials are discussing potential changes for deer management in Tennessee as chronic wasting disease continues to ...

Biomarkers associated with cognitive impairment differ between men and women with chronic kidney disease, according to data ...

When weird fungal epidemics crop up in far-flung places, scientists work together to unravel how the microscopic murderers show up and turn deadly. The Great Alaska Earthquake rocked Anchorage in 1964 ...

Background: Primary progressive aphasia (PPA) is a clinical syndrome defined by progressive deterioration of language with preservation of activities of daily living and evidence of relatively normal ...

Jascayd (nerandomilast) is now FDA-approved for progressive pulmonary fibrosis, expanding its use beyond idiopathic pulmonary fibrosis. The drug is a phosphodiesterase 4B inhibitor, offering targeted ...

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient ...

It can be a real pain in the neck. Rheumatoid arthritis, or RA, is an autoimmune disease in which the body mistakenly attacks the lining of the joints, causing painful swelling and stiffness. About ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...